COX-2 inhibitors: little or no GI protection, increased risk of cardiovascular events, high cost, and other class-less effects.
Curtiss
Frederic R
FR
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D004064:Digestive System / Q000187:drug effects*; D016527:Drug Costs; D006801:Humans; D018570:Risk Assessment
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors